Introduction
============

The diagnosis and treatment of persistent wound leakage is an important and poorly understood topic in the field of joint arthroplasty. Persistent wound leakage after total knee and hip arthroplasty is associated with a higher risk of developing periprosthetic joint infection (PJI).[@B1]-[@B5] PJI is a serious complication with great impact on a patient\'s physical functioning and quality of life. Moreover, PJI is a high financial burden for society. Additional medical costs of PJI are approximately €30,000 per patient,[@B6],[@B7] with even higher societal costs because of productivity loss, home care and informal care provided by relatives. Unfortunately, there are no evidence-based guidelines for the diagnosis and treatment of persistent wound leakage after joint arthroplasty.

Numerous issues hamper the development of sound guidelines. First of all, research on wound leakage is hard, as PJI is the major endpoint of wound leakage treatment, which has a low incidence.[@B8] Secondly, there is no uniformly accepted definition of wound leakage or when to call it persistent. This lack of clear definitions hampers comparison of clinical reports to such an extent that there is no clear evidence for any treatment modality for persistent wound leakage. Finally, in clinical practice the amount of drainage may also play a role in the decision-making process, e.g. agreement on the optimal treatment of severe persistent wound leakage is usually easier than agreement on the treatment of less severe wound leakage.

As a result of this lack of clarity, there is still insufficient evidence for the development of a clinical guideline. In 2013 consensus statements on current practices for prevention, diagnosis and management of PJI were developed during the first International Consensus Meeting (ICM) on PJI.[@B9] One of these statements suggested that wound leakage is considered to be persistent when it continues for more than three days after index surgery. Moreover, they stated that surgical management of persistent wound leakage should be performed without delay if wound leakage persists for five to seven days after index surgery.[@B10] However, there is no definitive evidence for these statements, as there have been no randomized controlled trials on persistent wound leakage.

Without a guideline, clinical practice in orthopaedic hospitals varies widely. Moreover, there is no insight into the modalities used for diagnosis and treatment of persistent wound leakage after joint arthroplasty. This paper reports the results of a questionnaire-based online survey among Dutch orthopaedic surgeons on current care for persistent wound leakage after joint arthroplasty. The survey is part of the preparation for a nationwide multicenter randomized controlled trial in the Netherlands on the optimal treatment of persistent wound leakage after total knee and hip arthroplasty.

Methods
=======

Procedure
---------

To evaluate current clinical practice of Dutch orthopaedic surgeons on persistent wound leakage after knee and hip arthroplasty, a questionnaire-based online survey was sent to all 700 members of the Netherlands Orthopaedic Association (NOV), working as orthopaedic surgeons in Dutch hospitals. Surveys completed by residents and members working outside the Netherlands were excluded. The web-based survey tool used for this questionnaire was google.forms. In January 2016 the questionnaire was disseminated by the NOV via e-mail invitation with a link to the survey. Reminder e-mails were sent after two and four weeks to increase the response rate. Data collection was closed six weeks after sending the first e-mail.

Questionnaire
-------------

The questionnaire consisted of 23 questions regarding the definition, classification, diagnosis and treatment of persistent wound leakage after arthroplasty ([Supplementary Material](#SM0){ref-type="supplementary-material"}). The questionnaire was developed by the LEAK-study group (LEakage After Knee and hip arthroplasty). This group was appointed by the Netherlands Orthopaedic Association (NOV) and its Consortium Orthopaedic Research (CORE), as part of the preparation for a nationwide multicenter randomized controlled trial on the treatment of persistent wound leakage after total knee and hip arthroplasty. The LEAK-study group involved 25 members who are experts in the field of prosthetic joint infections (orthopaedic surgeons, epidemiologists, researchers and an infectious disease specialist). Three consensus rounds were used to form the final questionnaire ([Supplementary Material](#SM0){ref-type="supplementary-material"}).

Statistical analyses
--------------------

Statistical analyses were performed using IBM SPSS Statistics (version 23.0, Chicago, USA). Results were analyzed using descriptive statistics.

Results
=======

Respondents
-----------

A total of 127 respondents filled in the questionnaire (18.1% of NOV members), representing 70 of all 103 institutions where knee and hip arthroplasty surgeries are performed (68.0%). Most respondents work in general non-training hospitals (61.4%) and 48.8% of the respondents had more than ten years of working experience (Table [1](#T1){ref-type="table"}).

Classification and definition of wound leakage
----------------------------------------------

Most respondents did not use a classification system for wound leakage (81.2%) (Table [2](#T2){ref-type="table"}). Of the 24 respondents who reported using a classification system, 12 referred to their definition of wound leakage in days (9.4%) and the other 12 all used different classification systems (9.4%).

Just over half of the respondents (51.2%) used a definition of persistent wound leakage, based on duration of wound leakage after index surgery (Table [2](#T2){ref-type="table"}). The used cut-off points showed a large range of 1 to 14 days. Of the 65 respondents who used a definition of persistent wound leakage, 24 defined wound leakage as persistent when present for more than five days (36.9%), 11 as present for more than seven days (16.9%) and 19 for more than ten days (29.2%) (Figure [1](#F1){ref-type="fig"}a).

Protocol for persistent wound leakage
-------------------------------------

More than half of the respondents used a protocol for diagnosis and treatment of persistent wound leakage (56.7%), but only 26.8% utilized the protocol in every patient. Patients were regularly discharged by 48.8% of the respondents regardless of wound leakage. A similar percentage of respondents almost never discharged patients with wound leakage (43.3%). The majority of respondents reported monitoring patients after discharge (90.2%), e.g. via telephone consultation (Table [2](#T2){ref-type="table"}).

Diagnostic modalities
---------------------

Most clinical parameters used to evaluate persistent wound leakage were redness (92.9%), fever (92.9%), pain (69.3%), course of recovery (67.7%) and/or swelling (52.7%). Warmth was evaluated by fewer respondents (38.6%). Nearly all respondents used a combination of at least three clinical parameters (86.6%) (Figure [2](#F2){ref-type="fig"}a). The most popular combination was redness, fever, course of recovery and pain (used by 42.5% of the respondents), with another 27.5% of the respondents evaluating these parameters in combination with warmth and swelling.

For inflammatory parameters, plasma C-reactive protein (CRP) was used as a diagnostic modality by 92.1% of respondents. Similarly, most (82.7%) perceived CRP as the most important inflammatory parameter in persistent wound leakage. Moreover, 70.9% of the respondents felt that the trend or dynamics of CRP are important.

Non-surgical treatment modalities
---------------------------------

The maximum period of persistent wound leakage before starting non-surgical treatment was 3 to 7 days according to most respondents (59.1%) (Figure [1](#F1){ref-type="fig"}b). 20.5% of respondents stated no maximum period before starting non-surgical treatment, as they only use surgical treatment modalities. The miscellaneous group used clinical presentation instead of the above-mentioned time-based parameter (10.2%).

Regarding non-surgical treatment modalities for persistent wound leakage most respondents used wound care (60.6%), bed rest (49.6%), pressure bandages (36.2%), admittance (23.6%) and antibiotics (23.6%). A wide variety of combinations was reported (in total 36), all comprising small groups (ranging from 1 to 8 respondents): 54.4% of the respondents used 1-2 non-surgical treatment modalities, 40.9% used 3-4 modalities and 4.7% reported using 5-7 modalities (Figure [2](#F2){ref-type="fig"}b). The most popular combination was admittance and wound care (5.5%).

Surgical treatment modalities
-----------------------------

Most respondents reported a maximum period of wound leakage before converting to surgical treatment of 10 days after index surgery (44.1%) (Figure [1](#F1){ref-type="fig"}c), yet with a wide range from 5 to 21 days. From the miscellaneous group (31.5%), 14 respondents favored a 14-day cut-off, while another 14 respondents stated basing their decision on aspects other than duration of wound leakage (e.g. type and/or amount of wound leakage, clinical parameters and/or inflammatory parameters).

The most-used surgical treatment modalities were lavage (96.1%), obtaining cultures (94.4%), surgical debridement (79.5%), antibiotics (77.2%) and exchange of mobile components (67.7%). The majority of the respondents (52.0%) favored a combined use of all these five treatment modalities as a surgical treatment regime; 34.6% of respondents used 3-4 surgical treatment modalities and 13.4% used 1-2 modalities (Figure [2](#F2){ref-type="fig"}c). The miscellaneous group (3.1%) comprised of two respondents using local gentamicin carriers, one removing the prosthesis and one other respondent performing only superficial debridement in case of an intact joint capsule and iliotibial tract.

Discussion
==========

In this online survey we evaluated current Dutch orthopaedic care for persistent wound leakage after joint arthroplasty. This survey revealed considerable variation in clinical practice among Dutch orthopaedic surgeons in terms of classification, definition, diagnosis and treatment of persistent wound leakage after joint arthroplasty. This variety in clinical practice is likely the result of a lack of evidence-based guidelines, caused by the scarce evidence on this topic.[@B1]-[@B5],[@B10]-[@B12]

Regarding the definition of persistent wound leakage after joint arthroplasty most respondents based the definition on the duration of wound leakage after index surgery. Preferred cut-off points were more than five days and more than ten days, yet with a large range (1 to 14 days). This lack of agreement is in accordance with reports in the literature, reporting using time (with a range of 2 to 7 days), presence of microbial content or type of secretion (purulent, hematogenous or clear) as definition.[@B1]-[@B5],[@B11]-[@B16] The ICM statements define persistent wound leakage as a wound leaking \>2 x 2cm for more than three days, arguing that this time frame would allow for earlier intervention and may limit the claimed adverse consequences (e.g. PJI). [@B10] Still, there is no scientific data confirming this statement.

In the Netherlands there is dearth of a uniform approach to the classification, definition, diagnosis and treatment of persistent wound leakage. Only 18.7% of respondents used a classification and all used a different classification. In the literature there is a complete lack of data regarding amount of wound leakage, while this amount and its dynamics play a large role in the decision-making process. This missing classification of type and amount of wound leakage impairs comparison and interpretation of the scarce literature on the topic.

This survey showed that there is no consensus on a protocol. Only 26.5% used a protocol consistently, and 30.5% did not use the protocol in all cases. In the literature only Maathuis et al. have described a standardized method to approach persistent wound leakage after arthroplasty.[@B1] Compared to an *ad hoc* approach, their algorithm resulted in fewer open debridements (17% versus 30%) and a higher salvage percentage (95% versus 85%).

The clinical parameters most respondents used when evaluating persistent wound leakage were redness, fever, pain, swelling and a course of recovery. A combination of at least two clinical parameters was used by nearly all respondents (96.9%). However, 24 different combinations were reported, underscoring an apparent lack of evidence and consensus for an optimal combination of clinical parameters.

Our results showed that orthopaedic surgeons used several clinical and inflammatory parameters to provide the necessary information to guide clinical decision-making. For inflammatory parameters, 92.1% of respondents used CRP at some point in their decision-making process. Moreover, most respondents reported CRP to be the primary parameter and 70.9% reported that the trend or dynamics of CRP are important - e.g. a rise in CRP is considered a worrisome sign, whereas a decrease is generally interpreted as a sign of absence of infection. Nevertheless, responses to the exact use of CRP were wide and diverse, probably in relation to the fact that an elevated CRP, as well as some other clinical infectious symptoms (such as fever and tachycardia), may be a physiological response in the early postoperative period.[@B17]-[@B23]

In this survey the maximum period of wound leakage before starting non-surgical treatment was three to seven days after index surgery. The most popular treatment modalities included wound care, bed rest, pressure bandages and/or antibiotics. Still, more than 30 combinations of treatment modalities were used, stressing the lack of consensus on optimal non-surgical treatment. Literature on this topic is limited, suggesting several days of immobilization,[@B15],[@B16] sterile dressings,[@B3] and/or antibiotics.[@B3] The use of antibiotics among 23.4% of respondents was a surprising and disturbing finding, as the efficacy of antibiotic treatment in persistent wound leakage after arthroplasty has not been studied. Antibiotics can also have substantial negative effects, such as increased risk of resistance, poor penetration into the biofilm, and complicated early diagnosis and treatment of infection, given that they can mask infection and confound culture findings.[@B10],[@B15] For these reasons, the ICM advises against the use of antibiotics in persistent wound leakage after joint arthroplasty.[@B9],[@B10]

Most respondents (43.8%) convert to surgical treatment if wound leakage is present for ten days after index surgery, implying a non-surgical treatment period of three to seven days. The literature offers little guidance on this topic, but suggests that wound leakage more than five to nine days after arthroplasty should be managed by surgical treatment to give a higher chance of preventing PJI.[@B2]-[@B4],[@B14],[@B16] Based on these findings, the ICM states that surgical treatment should be performed if wound leakage persists for more than five to seven days.[@B10] However, it seems reasonable to use parameters other than merely duration of wound leakage in the clinical decision-making process. In this survey a minority of respondents used other aspects, such as type or amount of wound leakage, clinical parameters and/or infectious parameters.

A total of 16 combinations were reported as surgical treatment protocol. The majority (52.3%) favored a combined protocol consisting of five modalities (surgical debridement, lavage, cultures, exchange of mobile components, and start of antibiotic treatment). These modalities are comparable to the ICM\'s, stating a moderate agreement on deep open debridement, cultures (\>3) and modular component exchange.[@B10],[@B24]

This survey can be viewed as a fair representation of the practices of the Dutch orthopaedic community. The main weakness of this study is that it is by design a questionnaire-based survey. Although this study design led to a relatively low response rate of 18.1% among all NOV members, the respondents represented the majority (68.0%) of orthopaedic clinics, which leads to a reasonable assumption that respondents provided a correct representation of clinical practice in the Netherlands. Respondents were not obliged to fill in the name of the hospital they worked in, since it was anticipated that orthopaedic surgeons could consider this a barrier for filling in the survey. Because of this, 15 respondents did not provide data on the hospital they worked in. Taking this into account, the actual representation of orthopaedic clinics may be even higher than 68.0%.

In conclusion, the data from this nationwide survey among Dutch orthopaedic surgeons on persistent wound leakage after joint arthroplasty demonstrated a wide variation in clinical practice of classification, definition, diagnosis and treatment of persistent wound leakage. This underscores the lack of consensus, which is mainly due to a dearth of clear evidence on the correct diagnosis and treatment of wound leakage. This survey may be representative for current daily clinical practice of the global orthopaedic community and stresses the need for further research on this important topic.
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:   Netherlands Orthopaedic Association

PJI

:   periprosthetic joint infection.
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###### 

Descriptives of respondents (n=127)

  Variable              Value                           Respondents (%)
  --------------------- ------------------------------- -----------------
  Clinic type           General hospital                78 (61.4%)
                        Orthopaedic training hospital   39 (30.7%)
                        University hospital             10 (7.9%)
  Experience in years   0-10                            65 (51.2%)
                        10-20                           38 (29.9%)
                        \>20                            24 (18.9%)

###### 

Definition, classification and protocol for wound leakage (n=127)

  Variable                                     Value                    Respondents (%)
  -------------------------------------------- ------------------------ -----------------
  Classification for wound leakage             Yes                      24 (18.8%)
                                               No                       103 (81.2%)
  Uniform definition of wound leakage          Yes                      65 (51.2%)
                                               No                       62 (48.8%)
  Uniform protocol in case of wound leakage    Yes, used in all cases   34 (26.8%)
                                               Yes, not always used     38 (29.9%)
                                               No                       55 (43.3%)
  Discharge patients with wound leakage        Yes, always              4 (3.2%)
                                               Yes, regularly           62 (48.8%)
                                               No, almost never         55 (43.3%)
                                               No, never                6 (4.7%)
  Monitoring wound leakage after discharge\*   Yes                      111 (90.2%)
                                               No                       12 (9.8%)

\* 4 missing values

[^1]: \* Frank-Christiaan B.M. Wagenaar and Claudia A.M. Löwik share a joined first authorship.

[^2]: Competing Interests: The authors have declared that no competing interest exists.
